EPISODE · Jun 7, 2022 · 32 MIN
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH
My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
What this episode covers
My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
NOW PLAYING
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.